ABSTRACTS OF THE DUTCH SOCIETY OF CLINICAL PHARMACOLOGY AND BIOPHARMACY MEETING OF MARCH 26, 2013 DOPAMINE D2 AGONIST INDUCED CARDIOVASCULAR CHANGES IN YOUNG HEALTHY MEN. A PHASE I CLINICAL TRIAL EXPERIENCE